Allworth Financial’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.54K	Buy	477 +45	+10%	+$349	﹤0.01%	4020
2025 Q4	$3.37K	Sell	432 -110	-20%	-$795	﹤0.01%	3919
2025 Q3	$4.11K	Sell	542 -65	-11%	-$541	﹤0.01%	3664
2025 Q2	$5.44K	Buy	607 +234	+63%	+$2.18K	﹤0.01%	3218
2025 Q1	$3.07K	Hold	373	–	–	﹤0.01%	3028
2024 Q4	$2.84K	Hold	373	–	–	﹤0.01%	3016
2024 Q3	$2.83K	Hold	373	–	–	﹤0.01%	2813
2024 Q2	$2.66K	Sell	373 -781	-68%	-$4.31K	﹤0.01%	2790
2024 Q1	$5.86K	Buy	1,154 +411	+55%	+$2.31K	﹤0.01%	2342
2023 Q4	$4.45K	Buy	743 +244	+49%	+$1.41K	﹤0.01%	2323
2023 Q3	$3.53K	Buy	499 +220	+79%	+$1.58K	﹤0.01%	2284
2023 Q2	$1.97K	Buy	279 +121	+77%	+$971	﹤0.01%	2494
2023 Q1	$1.32K	Buy	158 +38	+32%	+$366	﹤0.01%	2568
2022 Q4	$1.38K	Hold	120	–	–	﹤0.01%	2368
2022 Q3	$2K	Buy	120 +108	+900%	+$1.39K	﹤0.01%	2106
2022 Q2	$0	Buy	+12	New	+$124	﹤0.01%	2398
2018 Q2	–	Sell	-500	Closed	-$2K	–	940
2018 Q1	$2K	Hold	500	–	–	﹤0.01%	692
2017 Q4	$2K	Hold	500	–	–	﹤0.01%	648
2017 Q3	$3K	Buy	+500	New	+$2.56K	﹤0.01%	622